This article was
nominated for
deletion.
The discussion was closed on 23 December 2023 with a consensus to
merge the content into the article
Propranolol. If you find that such action has not been taken promptly, please consider assisting in the merger instead of re-nominating the article for deletion. To discuss the merger, please use
the destination article's talk page. (December 2023) |
The topic of this article may not meet Wikipedia's
notability guidelines for products and services. (August 2020) |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.365 g·mol−1 |
3D model ( JSmol) | |
| |
|
Idropranolol is a beta blocker that was never marketed. [1] [2]
This article was
nominated for
deletion.
The discussion was closed on 23 December 2023 with a consensus to
merge the content into the article
Propranolol. If you find that such action has not been taken promptly, please consider assisting in the merger instead of re-nominating the article for deletion. To discuss the merger, please use
the destination article's talk page. (December 2023) |
The topic of this article may not meet Wikipedia's
notability guidelines for products and services. (August 2020) |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.365 g·mol−1 |
3D model ( JSmol) | |
| |
|
Idropranolol is a beta blocker that was never marketed. [1] [2]